M6X3.F · Yield10 Bioscience, Inc

-

Please sign in to comment on M6X3.F

1 Comment

Admin

4 years ago

Yield10 Bioscience, Inc is currently in a long term downtrend where the price is trading 13.3% below its 200 day moving average.

From a valuation standpoint, the stock is 84.9% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 37.6.

Yield10 Bioscience, Inc's total revenue rose by 39.3% to $195K since the same quarter in the previous year.

Its net income has increased by 61.4% to $-3M since the same quarter in the previous year.

Finally, its free cash flow grew by 27.7% to $-2M since the same quarter in the previous year.

Based on the above factors, Yield10 Bioscience, Inc gets an overall score of 4/5.

Exchange	F
CurrencyCode	EUR
ISIN	US98585K8624
Sector	Basic Materials
Industry	Agricultural Inputs

PE Ratio	None
Target Price	23.33
Beta	1.61
Market Cap	140K
Dividend Yield	None

ABOUT

Yield10 Bioscience, Inc

Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focuses on commercializing products using the Camelina oilseeds. Its products include Camelina oil for use as a low-carbon feedstock oil for biofuels; Omega-3 oils for human nutrition; and PHA bioplastics. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

M6X3.F · Yield10 Bioscience, Inc

-

Yield10 Bioscience, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Yield10 Bioscience, Inc using a moving average strategy